Is AtaiBeckley Inc. (ATAI) Stock a Psychedelic Medicine Opportunity Ahead of Phase 2 Results?

TheFly reported connected July 7 that Canaccord accrued its terms people connected ATAI to $17 from $15 portion maintaining a Buy standing connected the shares. The steadfast revised its exemplary pursuing the company's announcement that it had completed dosing the last subordinate successful the Elumina Phase 2 survey evaluating VLS-01, a DMT buccal film, for treatment-resistant depression. Canaccord noted that ATAI remains connected way to study topline results successful the 4th fourth of 2026.

On July 6, AtaiBeckley Inc. (NASDAQ:ATAI) announced the completion of diligent dosing successful its Phase 2b Elumina objective proceedings evaluating VLS-01 successful adults with treatment-resistant depression. The multi-center, double-blind, placebo-controlled survey enrolled 156 participants, with topline results expected successful the 4th fourth of 2026. The institution plans to advancement VLS-01 into Phase 3 improvement for large depressive disorder, portion generalized anxiousness upset remains a imaginable aboriginal indication. ATAI stated that VLS-01, alongside BPL-003, which is presently successful Phase 3 improvement for treatment-resistant slump with Breakthrough Therapy Designation, could enactment a broader attack to treating temper and anxiousness disorders.

AtaiBeckley Inc. (NASDAQ:ATAI) is simply a clinical-stage biopharmaceutical institution formed done the merger of Atai Life Sciences and Beckley Psytech, focused connected processing fast-acting, long-lasting psychedelic-based treatments for difficult-to-treat intelligence wellness disorders.

While we admit the imaginable of ATAI arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.